Publications

Detailed Information

Durability of Clinical Benefit and Biomarkers in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Sotorasib, a KRAS(G12C) Inhibitor

DC Field Value Language
dc.contributor.authorHong, D. S.-
dc.contributor.authorBang, Yung-Jue-
dc.contributor.authorBarlesi, F.-
dc.contributor.authorDurm, G.-
dc.contributor.authorFalchook, G.-
dc.contributor.authorGovindan, R.-
dc.contributor.authorDy, G.-
dc.contributor.authorPark, K.-
dc.contributor.authorStrickler, J.-
dc.contributor.authorBurns, T.-
dc.contributor.authorKim, J.-
dc.contributor.authorAng, A.-
dc.contributor.authorLipford, J. R.-
dc.contributor.authorNgarmchamnanrith, G.-
dc.contributor.authorAnderson, A.-
dc.contributor.authorLi, B. T.-
dc.date.accessioned2024-03-25T05:03:54Z-
dc.date.available2024-03-25T05:03:54Z-
dc.date.created2024-03-21-
dc.date.created2024-03-21-
dc.date.issued2021-01-
dc.identifier.citationJournal of Thoracic Oncology, Vol.16 No.1, pp.S28-S29-
dc.identifier.issn1556-0864-
dc.identifier.urihttps://hdl.handle.net/10371/199249-
dc.language영어-
dc.publisherElsevier Inc.-
dc.titleDurability of Clinical Benefit and Biomarkers in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Sotorasib, a KRAS(G12C) Inhibitor-
dc.typeArticle-
dc.identifier.doi10.1016/j.jtho.2020.10.136-
dc.citation.journaltitleJournal of Thoracic Oncology-
dc.identifier.wosid000610079600058-
dc.citation.endpageS29-
dc.citation.number1-
dc.citation.startpageS28-
dc.citation.volume16-
dc.description.isOpenAccessY-
dc.contributor.affiliatedAuthorBang, Yung-Jue-
dc.type.docTypeMeeting Abstract-
dc.description.journalClass1-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Related Researcher

  • College of Medicine
  • Department of Medicine
Research Area Clinical Medicine

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share